Delivery Order SPE2DB24D8002-SPE2DB25FJMXP

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,511.06 firm-fixed-price contract is for the delivery of VEMLIDY 25 MG TABLET in support of U.S. Armed Forces medical operations. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) that allows the company to provide a comprehensive range of pharmaceutical products,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,120.76, is for the delivery of Vemlidy 25 mg Tablet with an ultimate completion date of April 16, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC, which is part of...
This federal contract award, identified as SPE2DB24D8002 and SPE2DB25FJMMP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The $6,236.68 firm fixed-price delivery order is for the provision of VEMLIDY 25 MG TABLET, a pharmaceutical product. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The company has significant experience supporting the DLA's medical supply...
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2VE8, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Firm Fixed Price Delivery Order valued at $5,535.19, with a performance period extending through March 4, 2024. The contract is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, has been awarded a firm fixed price delivery order valued at $6,195.56 by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Under this contract, Dakota Drug will provide 25 mg tablets of VEMLIDY, a medication used to treat hepatitis B virus infection, to Minot, North Dakota in quantities of 30 tablets per unit. No set-aside was designated for this...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of the pharmaceutical product Viibryd 20 mg tablets, with a ceiling value of $1,309.00 and a period of performance through August 29, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical's ECAT Generation V Program. The contract is for the delivery of pharmaceutical products, including medications such as Trulicity, Mounjaro, Entresto, Stelara, Dupixent, and various vaccines, to support U.S. Armed Forces medical operations. The contract has a firm fixed price, a ceiling value of $2,785.81, and a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $15,860.63, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of March 20, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of VEMLIDY 25 MG TABLET. The contract has a firm fixed price ceiling value of $2,643.72 and a completion date of June 27, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the DLA to efficiently...
This is a delivery order contract (SPE2DB24D8002/SPE2DB25FJNCT) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a ceiling value of $10,364.55 and a completion date of February 10, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC)...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJMXP
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a firm fixed-price of $13,373.39 and a completion date of January 7, 2025. The contract provides for the delivery of VEMLIDY 25 MG TABLET to support the medical supply needs of the U.S. Armed Forces.

Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company to deliver a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to various defense healthcare facilities. The current delivery order is not set aside for any particular business category.

Generated 5/21/25, 10:37 AM